Alnylam Pharmaceuticals (A1LN34.SA) Q1 2014 Earnings

13FebConfirmed
Q1 1
Q3 2013
Q4 2013
Q1 2014
-3.59
-2.62
-1.64
-0.66

Details

Expected EPS
N/A
Actual EPS
-1.2193589999999999
Surprise EPS
-1.22
Surprise Percent
+∞%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -1.2193589999999999 per share for Q1 2014.

0 Comments

Share your thoughts